KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nasdaq (NDAQ) Research & Development (2016 - 2025)

Nasdaq's Research & Development history spans 17 years, with the latest figure at $80.0 million for Q4 2025.

  • For Q4 2025, Research & Development rose 8.11% year-over-year to $80.0 million; the TTM value through Dec 2025 reached $316.0 million, up 12.46%, while the annual FY2025 figure was $316.0 million, 12.46% up from the prior year.
  • Research & Development for Q4 2025 was $80.0 million at Nasdaq, roughly flat from $80.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $80.0 million in Q3 2025 and bottomed at $44.0 million in Q1 2021.
  • The 5-year median for Research & Development is $57.5 million (2022), against an average of $61.2 million.
  • The largest annual shift saw Research & Development surged 31.43% in 2021 before it grew 6.38% in 2022.
  • A 5-year view of Research & Development shows it stood at $49.0 million in 2021, then grew by 16.33% to $57.0 million in 2022, then grew by 14.04% to $65.0 million in 2023, then rose by 13.85% to $74.0 million in 2024, then increased by 8.11% to $80.0 million in 2025.
  • Per Business Quant, the three most recent readings for NDAQ's Research & Development are $80.0 million (Q4 2025), $80.0 million (Q3 2025), and $79.0 million (Q2 2025).